First patient treated with Leqembi® (lecanemab) in Sweden

BioArctic announced that Leqembi is now available at a private clinic in Sweden, with the first Swedish patient beginning treatment outside the public healthcare system. The milestone expands real-world access to the Alzheimer's treatment in Sweden, though the announcement provides no revenue, sales-volume, or broader reimbursement details.